A Bioorthogonal Ratiometric Fluorescence Nanoprobe for Imaging the Regulation of O‐GlcNAcylation in Atherosclerosis
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Jiheng Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, Shandong University, Jinan, P. R. China. Hauptthemen laut MEDLINE: Atherosclerosis, Fluorescent Dyes, Acetylglucosamine, Nanoparticles. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Local Science and Technology Development Fund Guided by the Central Government of Shandong Province.
Abstract (Originalsprache)
Protein post‐translational modification (PTM) plays a significant role in the progression of atherosclerosis (AS). However, the role of O‐GlcNAcylation, as an important O‐glycosylation modification, in the formation of foam cells remains unclear, limiting early diagnosis and mechanistic studies. Here, utilizing two bioorthogonal reactions, we developed a ratiometric fluorescent nanoprobe‐based tracker for O‐GlcNAcylation. This tracker (BORFI) enables dynamic tracing, relative quantification, and multi‐scale in situ visualization of protein O‐GlcNAcylation during cellular events, and images the regulation of O‐GlcNAcylation during foam cell formation. Using BORFI, we successfully achieved spatiotemporal co‐imaging of O‐GlcNAcylation and reactive oxygen species (ROS), and found that there is a significant positive correlation between O‐GlcNAcylation and ROS during the transition from macrophages to foam cells. Treatment with the OGT enzyme inhibitor (OSMI‐1) to affect the O‐GlcNAcylation level in foam cells effectively alleviates foam cell formation, accompanied by suppression of the overall increase in ROS levels, modulation of key cholesterol metabolism‑related proteins (downregulation of ACAT1 and upregulation of ABCA1), and downregulation of the scavenger receptor MSR1. Furthermore, BORFI was successfully applied to in situ imaging of the aorta in a mouse AS model, and we found that hyperglycemia participates in AS progression by specifically upregulating vascular O‐GlcNAcylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Engineering, Shandong University, Jinan, P. R. China.
- College of Chemistry, Chemical Engineering and Materials Science, Shandong Normal University, Jinan, P. R. China.
- Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, P. R. China.
- Laoshan Laboratory, Qingdao, P. R. China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Local Science and Technology Development Fund Guided by the Central Government of Shandong Province
Zitieren
APA
Xu, J., Zhang, W., Li, P., Tang, Y., Zhang, W., Wang, H., & Tang, B. (2026). A Bioorthogonal Ratiometric Fluorescence Nanoprobe for Imaging the Regulation of O‐GlcNAcylation in Atherosclerosis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71595
Vancouver
Xu J, Zhang W, Li P, Tang Y, Zhang W, Wang H, et al. A Bioorthogonal Ratiometric Fluorescence Nanoprobe for Imaging the Regulation of O‐GlcNAcylation in Atherosclerosis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71595
BibTeX
@article{Xu2026,
author = {Xu, Jiheng and Zhang, Wei and Li, Ping and Tang, Yue and Zhang, Wen and Wang, Hui and Tang, Bo},
title = {A Bioorthogonal Ratiometric Fluorescence Nanoprobe for Imaging the Regulation of O‐GlcNAcylation in Atherosclerosis},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71595}
}
EUVIMED